Company Ophthotech Corp Nasdaq
Equities
US6837451037
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Glenn Sblendorio
CEO | Chief Executive Officer | 68 | 13-06-30 |
Mark Reisenauer
PSD | President | 58 | 23-07-10 |
Xiao Ping Dai
CTO | Chief Tech/Sci/R&D Officer | - | - |
Keith Westby
COO | Chief Operating Officer | 49 | 17-01-28 |
Evelyn Harrison
CTO | Chief Tech/Sci/R&D Officer | - | 07-07-31 |
Kathy Galante
IRC | Investor Relations Contact | - | 13-11-12 |
Corporate Officer/Principal | 49 | 21-08-01 | |
Amy Sheehan
HRO | Human Resources Officer | - | 13-12-31 |
Dhaval Desai
PRN | Corporate Officer/Principal | - | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Sblendorio
CEO | Chief Executive Officer | 68 | 13-06-30 |
Mark Reisenauer
PSD | President | 58 | 23-07-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 137,976,851 | 137,657,408 ( 99.77 %) | 0 | 99.77 % |
Company contact information
![address Ophthotech Corp](https://cdn.zonebourse.com/static/address/14368668.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |